- Home
- PXLW vs CLNN Comparison
PXLW vs CLNN Comparison
Compare PXLW & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- CLNN
- Stock Information
- Founded
- PXLW 1997
- CLNN 2012
- Country
- PXLW United States
- CLNN United States
- Employees
- PXLW N/A
- CLNN N/A
- Industry
- PXLW Semiconductors
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- PXLW Technology
- CLNN Health Care
- Exchange
- PXLW Nasdaq
- CLNN Nasdaq
- Market Cap
- PXLW 41.8M
- CLNN 43.0M
- IPO Year
- PXLW 2000
- CLNN N/A
- Fundamental
- Price
- PXLW $0.81
- CLNN $4.61
- Analyst Decision
- PXLW Strong Buy
- CLNN Strong Buy
- Analyst Count
- PXLW 3
- CLNN 4
- Target Price
- PXLW $2.17
- CLNN $59.25
- AVG Volume (30 Days)
- PXLW 243.1K
- CLNN 53.4K
- Earning Date
- PXLW 11-12-2024
- CLNN 11-13-2024
- Dividend Yield
- PXLW N/A
- CLNN N/A
- EPS Growth
- PXLW N/A
- CLNN N/A
- EPS
- PXLW N/A
- CLNN N/A
- Revenue
- PXLW $54,190,000.00
- CLNN $421,000.00
- Revenue This Year
- PXLW N/A
- CLNN N/A
- Revenue Next Year
- PXLW $32.81
- CLNN $1,058.37
- P/E Ratio
- PXLW N/A
- CLNN N/A
- Revenue Growth
- PXLW N/A
- CLNN N/A
- 52 Week Low
- PXLW $0.61
- CLNN $3.82
- 52 Week High
- PXLW $3.08
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- PXLW 59.04
- CLNN 38.38
- Support Level
- PXLW $0.66
- CLNN $4.65
- Resistance Level
- PXLW $0.71
- CLNN $6.04
- Average True Range (ATR)
- PXLW 0.05
- CLNN 0.48
- MACD
- PXLW 0.01
- CLNN -0.14
- Stochastic Oscillator
- PXLW 83.29
- CLNN 11.08
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).